Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study.
Dolutegravir resistance is an increasing concern. An analysis of the DTG RESIST study found that among 227 integrase sequences from 7 African countries (all non-B subtypes), 59 (26.0%) had at least 1 major drug resistance mutation (primarily G118R and E138A/K/T), with 49 (21.6%) predicted to have high-level resistance to dolutegravir.
Institutions
- Institut für Soziale Arbeit (DE)
Publication Details
- Journal
- Open Access CRIS of the University of Bern
- Published
- 2025-05-20
- DOI
- https://doi.org/10.48620/89528
- Primary Topic
- Sports Performance and Training
- Type
- article
- Field-Weighted Citation Impact
- 0.00